Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07536789
Recruiting
Becotatug Vedotin (MRG003) in Previously Treated Advanced Hepatocellular Carcinoma
Phase 2 · China · 1 site
Registry update: 21 Apr 2026
NCT07221214
Recruiting
GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
Phase 2 · United States · 1 site
Registry update: 26 May 2026
2024-514874-36-01
Recruiting
An investigational trial to evaluate the effects of the drug XC001 delivered via a catheter in subjects with chronic angina caused by coronary artery disease (EXACT-2 Trial)
Phase 2 · Belgium, Germany, Hungary, Netherlands, Poland · 26 sites
Registry update: 4 Sept 2026
Conflicting statuses (not updated in the registry for 2 months)
NCT07532226
Recruiting
A Study of Guselkumab Treatment Persistence in Psoriatic Arthritis Participants
Not applicable · France · 1 site
Registry update: 3 Nov 2026
NCT07542041
Recruiting
Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens
Not applicable · United States · 1 site
Registry update: 18 Aug 2026
NCT07601178
Recruiting
QUEEN-APPLE: A Single-Arm, Multicenter, Prospective Phase II Clinical Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Anlotinib Hydrochloride and Nab-Paclitaxel as First-Line Treatment for Advanced Triple-Negative Breast Cancer
Phase 2 · China · 1 site
Registry update: 22 May 2026
NCT07549516
Recruiting
A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in the Chronic Phase in Germany
Not applicable · Germany · 59 sites
Registry update: 7 Oct 2026
NCT07387328
Recruiting
Validation of New sEMG Electrode Placement Guidelines for the Triceps Surae in Post-stroke Individuals
Not applicable · Belgium · 1 site
Registry update: 3 Jun 2026
NCT07290387
Recruiting
Tele-Savvy for Latino Caregivers
Not applicable · United States · 1 site
Registry update: 14 May 2026
NCT07546500
Recruiting
A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
Phase 3 · Australia, Belgium, Canada, Germany, Spain, France, Ireland, Italy, South Korea, Poland, Taiwan, United States · 59 sites
Registry update: 12 Aug 2026
NCT07137338
Recruiting
A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy
Phase 1 · United States · 3 sites
Registry update: 1 Oct 2026
NCT06923475
Recruiting
Neoadjuvant Gemcitabine and Cisplatin in Combination With Perioperative Pembrolizumab Versus Upfront Surgery for Patients With Primary Resectable and Borderline Resectable Perihilar and Distal Cholangiocarcinoma
Phase 2/3 · Netherlands · 1 site
Registry update: 25 Aug 2026
NCT07284082
Recruiting
The Synergistic Effects of Menopause and HIV on Cardiovascular Disease Risk in Women
Not applicable · United States · 1 site
Registry update: 22 Apr 2026
NCT07058012
Recruiting
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
Phase 2 · United States · 13 sites
Registry update: 3 Sept 2026
NCT07428629
Recruiting
Piloting an Insomnia Treatment in Patients With Ulcerative Colitis
Not applicable · United States · 1 site
Registry update: 28 Aug 2026
NCT07753343
Recruiting
Identification and Description of Patients With High-risk Non Metastatic RCC
Not applicable · France · 1 site
Registry update: 7 Aug 2026
2024-516898-72-00
Recruiting
Neoadjuvant gemcitabine and cisplatin in combination with perioperative pembrolizumab versus upfront surgery for patients with primary resectable and borderline resectable perihilar and distal cholangiocarcinoma (NEODISCO): A Multicentre Phase 2B/3 Randomised Controlled Trial
Phase 2/3 · Netherlands · 5 sites
Registry update: 21 Nov 2025
NCT07556640
Recruiting
LM-302 and S-1 Plus Intraperitoneal Paclitaxel With or Without Cadonilimab for Claudin 18.2-positive Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis: a Prospective, Exploratory Study
Phase 2 · China · 1 site
Registry update: 29 Apr 2026
NCT07453459
Recruiting
Feasibility of HPV Self-Collection Kits for Cervical Cancer Screening
Not applicable · United States · 1 site
Registry update: 27 Jul 2026
NCT07545317
Recruiting
Real-World Study of IL-23 Inhibitors in Active Crohn's Disease
Not applicable · China · 1 site
Registry update: 9 Jul 2026

Ordered by registry start date. Freshness and sponsorship never change the order.